| Identification | Back Directory | [Name]
Voriconazole Vfend | [CAS]
173967-54-9 | [Synonyms]
Vrc
Vfend
VRC-d3
Drg-0301
Vfend-d3
Voriconazol-d3
Unii-jfu09I87tr
Voriconazole Vfend
(αR,βS)-α-(2,4-Difluorophenyl)-5-fluoro-β-(Methyl-d3)-α-(1H-1,2,4-triazol-1-ylMethyl)-4-pyriMidineethanol
(R-(R*,S*))-alpha-(2,4-Difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol
4-Pyrimidineethanol, alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-, (R-(R*,S*))- | [Molecular Formula]
C16H14F3N5O |
| Hazard Information | Back Directory | [Definition]
ChEBI:Voriconazole is a triazole-based antifungal agent used for the treatment of esophageal candidiasis, invasive pulmonary aspergillosis, and serious fungal infections caused by Scedosporium apiospermum and Fusarium spp. It is an inhibitor of cytochrome P450 2C9 (CYP2C9) and CYP3A4. It has a role as a P450 inhibitor. It is a member of pyrimidines, a difluorobenzene, a tertiary alcohol, a triazole antifungal drug and a conazole antifungal drug. |
|
| Company Name: |
AVP Pharma Associates
|
| Tel: |
08048372655Ext 608 |
| Website: |
https://www.chemicalbook.com/ShowSupplierProductsList1932935/0.htm |
|